[Is Herceptin(®) (trastuzumab) by subcutaneous a mini revolution? Pharmaco-economic study]. [electronic resource]
- Bulletin du cancer Mar 2015
- 270-6 p. digital
Publication Type: English Abstract; Journal Article; Review
1769-6917
10.1016/j.bulcan.2015.01.007 doi
Administration, Cutaneous Antibodies, Monoclonal, Humanized--administration & dosage Antineoplastic Agents--administration & dosage Breast Neoplasms--drug therapy Drug Administration Schedule Female Humans Time Factors Trastuzumab